繁 | EN
Building a Healthier Future Together: HKAPI Celebrates Its 58th Anniversary Dinner
On 25 June 2026, the Hong Kong Association of Pharmaceutical Industry (HKAPI) joyfully celebrated its 58th Anniversary Dinner — a milestone evening that united approximately 300 distinguished guests in a shared vision for the future of healthcare in Hong Kong.

The evening brought together an exceptional cross-section of leaders and partners, including government representatives from The Executive Council, The Legislative Council, The Health Bureau, the Innovation, Technology and Industry Bureau, and the Pharmaceutical Administration Bureau (ISAF) of Macao SAR, among others.

We were equally delighted to welcome leading academics alongside medical societies, biotechnology and pharmaceutical industry partners, patient groups, and business and trade partners. A special thank you goes to the Hong Kong Tourism Board for the charming table gifts featuring Hong Kong’s most iconic symbols.

The evening was officially set in motion by HKAPI President Ms. Peggy Fung, whose welcome speech powerfully anchored the night’s theme. She reminded guests that sustainability is all about balance — delivering high-quality, patient-centred care while ensuring our healthcare system remains financially viable and resilient for the future. Peggy emphasised that  when viewed holistically, innovation is not merely a cost to be counted, but a long-term investment that improves health outcomes, enhances productivity, and strengthens the sustainability of Hong Kong’s healthcare system.

One of the most memorable highlights of the evening was a vibrant panel discussion on the theme “Innovation for a Sustainable Healthcare System”, featuring Guest of Honour Dr. Libby Lee, Chief Executive of the Hospital Authority of HKSAR, Professor Juliana Chan, Professor of Medicine and Therapeutics and Director of the Hong Kong Institute of Diabetes and Obesity at The Chinese University of Hong Kong, and Ms. Peggy Fung, moderated by Dr. David Lam, Medical and Health Representative of the Legislative Council of HKSAR.

The panellists shared powerful insights on how the pharmaceutical industry, the Hospital Authority, and academia are deeply and inextricably connected — not only in their collective mission to build a better healthcare system and drive improved patient outcomes for Hong Kong, but also in their mutual reliance on one another for sustainability and growth. 

“Industry die, we die — we die, industry also die.”

— Dr. Libby Lee delivered one of the most striking lines of the evening, frankly acknowledging that the Hospital Authority and the pharmaceutical industry are mutually dependent. She called for a shift away from the historically “hostile” attitude of healthcare managers toward the industry, and expressed the Hospital Authority’s eagerness to partner with pharmaceutical companies on real-world data studies.

The discussion highlighted the importance of closer collaboration in clinical trials, real-world evidence generation, and value-based healthcare decision-making. Panellists also emphasised that innovation must deliver meaningful value to patients and the healthcare system, and that stronger partnerships across government, hospitals, industry, and academia will be essential to improving access to new therapies and supporting a more sustainable healthcare future.
The discussion also explored how Hong Kong can further strengthen its position as a hub for clinical research and biomedical innovation. With its strong academic institutions, high-quality clinical data, and well-established healthcare infrastructure, Hong Kong was recognised as being uniquely placed to advance evidence-based innovation. The panel also touched on the need for more flexible and forward-looking access models, including outcome-based approaches and closer cooperation on financing and market access, so that innovative treatments can reach patients in a timely and sustainable way.
As the evening drew to a close, the discussion left guests with a strong sense of optimism and purpose. The shared message from the stage was clear: only through collaboration, innovation, and a collective commitment to patient-centred care can Hong Kong continue to build a healthcare system that is resilient, inclusive, and future-ready.

To every guest who joined us on this special occasion — thank you from the bottom of our hearts. Your presence, passion, and partnership make HKAPI’s journey all the more meaningful. Here’s to continued collaboration, innovation, and a healthier future for all.

Strengthening Ethical Standards: HKAPI Holds Code of Practice Train-the-Trainer Workshop
Close Bitnami banner
Bitnami